← Back to Search

Lidocaine Injections for Labor Pain

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years old
Be older than 18 years old
Must not have
Women undergoing cesarean delivery
Neurocardiogenic signs or symptoms (e.g., dizziness, lightheadedness, bradycardia, and syncope) during IV cannulation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedure (during lidocaine administration and at epidural tuohy needle insertion)
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare the pain experienced during the insertion of an epidural needle in women giving birth, with and without the use of lidocaine. Two different pain assessment tools will be used to

Who is the study for?
This trial is for women in labor who want epidural analgesia to manage pain. Participants must be eligible for the study based on their medical history reviewed before surgery. There are no specific inclusion or exclusion criteria provided.
What is being tested?
The study compares two ways of giving lidocaine, a numbing medication, before inserting an epidural needle: one group gets it under the skin (subcutaneous), and another just below the surface of the skin (intradermal). Pain levels will be measured using two scales by someone who can't see which method was used.
What are the potential side effects?
Possible side effects from lidocaine injections include temporary pain at injection site, redness, swelling, and rarely allergic reactions. The procedure may also cause changes in heart rate and blood pressure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am having a cesarean delivery.
Select...
I experience dizziness or fainting when getting an IV.
Select...
I have received IV magnesium sulfate in the last 24 hours.
Select...
I have diabetes (Type I or II).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, procedure (during lidocaine administration and at epidural tuohy needle insertion)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, procedure (during lidocaine administration and at epidural tuohy needle insertion) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The Critical-Care Pain Observation Tool (CPOT)
Secondary study objectives
Blood pressure (BP)
Heart Rate (HR)
Numerical rating score (NRS) for pain
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: INTRADERMALActive Control1 Intervention
Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine either intradermally (Group Intradermal).
Group II: SUBCUTANEOUSActive Control1 Intervention
Prior to insertion of the Tuohy epidural needle, each patient will receive an injection of 3 mL 1% lidocaine subcutaneously (Group Subcutaneous).

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,107 Total Patients Enrolled
~23 spots leftby Nov 2025